GlassScriptPhysician profile
Kristy E Belone
NPI 1013381268
$6,455.20
in general payments reported to CMS, 2019-2025
18 companies · $1,493 in 2025
The $1,493 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,081 · 2022: $971 · 2023: $1,348 · 2024: $1,562 · 2025: $1,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,404.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $2,150.82 | 2022-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $954.42 | 2021-2025 | Lifevest |
| Abbott Laboratories | $424.81 | 2022-2025 | Mitraclip, Triclip |
| Boston Scientific Corporation | $374.98 | 2021-2022 | |
| Amgen INC. | $371.70 | 2024-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $357.83 | 2023-2025 | Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $321.52 | 2021-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $244.81 | 2021-2024 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $244.57 | 2021-2022 | |
| Abiomed | $238.20 | 2023-2024 | Impella |
| Janssen Pharmaceuticals, INC | $137.63 | 2021-2023 | Xarelto |
| Genentech USA, INC. | $125.00 | 2021 | |
| Esperion Therapeutics, INC. | $124.98 | 2021 | |
| Inspire Medical Systems, INC. | $117.16 | 2022 | |
| Merck Sharp & Dohme LLC | $90.55 | 2023 | Verquvo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $73.15 | 2022 | |
| Ancora Heart, INC. | $58.24 | 2025 | Accucinch |
| Cardiac Dimensions, INC. | $44.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristy Belone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.